Breaking News

GEA builds process plant for the production of immunoglobulin

The CSL Behring facility in Bern has been improved on previous modules with a purely manual switchover panel could be ...

Samsung Biologics plans $2bn 'Super Plant' for biomanufacturing

The company has also said that it is in negotiations with the authorities at Incheon Free Economic Zone to purchase ...

Iovance chooses Avid for CDMO services

The deal is to support development of IOV-3001, a novel antibody cytokine engrafted protein

What can the pharmaceutical industry do to ensure it’s ready for a future pandemic?

The COVID-19 pandemic has stretched healthcare suppliers, organisations, governments and medical professionals to their ...

Catalent receives FDA approval as an additional manufacturing site for AveXis' Gene Therapy

The global provider of advanced drug delivery technologies will produce the commercial drug substance intermediate for ...

Second API supplier for BARHEMSYS receives FDA approval

The US FDA has approved Acacia Pharma Group as a second supplier for the active pharmaceutical ingredient for BARHEMSYS ...

Cleanroom Conference and Manufacturing Chemist Live events set to go ahead

The co-located events will go ahead in October with new safety measures in place, after being postponed from their ...

Redx signs licensing agreement with AstraZeneca for porcupine inhibitor

AstraZeneca will take RXC006 forward into clinical development, targeting fibrotic diseases including idiopathic ...

Viva Biotech acquires Langhua for CDMO service chain capabilities

Shanghai-based Viva has acquired Langhua to enable it to conduct vertical integration and expansion into CDMO business

Non-clinical safety evaluation of vaccines: accelerating clinical development (part II)

This white paper discusses regulatory expectations for the non-clinical development of vaccines, such as safety, ...

Delivering success for inhaled drug development programmes

No two inhaled drug development programmes will have exactly the same characteristics or drivers; so, to ensure the ...

Delivering an effective COVID-19 vaccine at record speed

COVID-19 is not the first pandemic that we’ve faced but, based on its ease and speed of transmission, it’s ...

Charles River acquires cellular specialist Cellero

Charles River has acquired Cellero to complement recent acquisition of HemaCare by enhancing the supply of critical ...

Biologics specialist Abzena receives $10m

Abzena has tripled GMP manufacturing capacity in the first half of 2020

Inspiration and Learning

People

Reports